Amendment Four.pdf
PDF 159 KB Posted
- Solicitation number
- 75N93024R00003
About this file
This document is Amendment Four to Solicitation 75N93024R00003 for "Interventional Agents Safety and Pharmacokinetic Services." The amendment addresses questions regarding the contract type, confirming that offerors may propose either cost-reimbursement or firm-fixed-price contracts for Task Area A. If a firm-fixed-price contract is proposed for Task Area A, the cost-reimbursement requirements will not apply.
The solicitation seeks to establish multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contracts to provide preclinical and non-clinical development support for promising therapeutic candidates against agents of bioterrorism, drug-resistant pathogens, and emerging/re-emerging infectious diseases. The contract will include services across six technical Task Areas: Product Development Planning, Non-GLP Preclinical Safety Studies, Non-GLP Preclinical Microbiological/Safety/Toxicology/PK, GLP Preclinical Microbiological/Safety/Toxicology/PK, Commercial Off-the-Shelf ADME/Safety/PK Screening, and Contract Kick-Off Meeting. The anticipated contract start date is May 1, 2025, with a seven-year ordering period.
View the file
Other files
Show all 30
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
75N93024R00003 Page 1 of 2
AMENDMENT #4
75N93024R00003
“INTERVENTIONAL AGENTS SAFETY AND PHARMACOKINETIC SERVICES”
AMENDMENT No. 4
Amendment Number: Four (4)
Amendment Issue Date: April 18, 2024
Proposal Due Date: May 24, 2024, 3:00PM EST (UNCHANGED)
Issued By:
Miranda Adams Contracting Officer Office of Acquisitions, DEA National Institute of Allergy and Infectious Diseases National Institutes of Health 5601 Fishers Lane
MSC 9821
Rockville, Maryland 20852-9821
Point of Contact:
Miranda Adams, Contracting Officer Email: miranda.adams@nih.gov.
Offerors must acknowledge receipt of the final posting of Amendment #4, on each copy of the proposal submitted. Failure to receive your acknowledgment of this Amendment may result in the rejection of your proposal.
The hour and date specified for receipt of proposals HAS NOT been extended.
PURPOSE OF SOLICITATION AMENDMENT:
The purpose of this amendment is to address questions regarding 75N93024R00003.
Question 1: Would NIAID consider proposals from offerors who propose either a cost-reimbursement or a firm fixed price type contract for Task Area A? If NAID is open to considering a firm fixed price proposal for Task Area A, would NIAID confirm that cost-reimbursement requirements (i.e., maintaining an adequate accounting system for cost-reimbursable contracts, providing breakdown direct and indirect costs and profit, direct labor rates, fringe benefits, overhead, and G&A expenses) will not apply?
Answer 1: Offerors are welcome to propose a firm fixed contract for Task Area A. Offerors are welcome to propose either a cost reimbursement or firm fixed for the Task Areas. If an offeror proposes a firm fixed price for a task area, the cost reimbursement requirements will not be required.
mailto:miranda.adams@nih.gov.
75N93024R00003 Page 2 of 2
AMENDMENT #4
End of Amendment 4
File details come from the government source that posted it. Updated .